Literature DB >> 11849914

Pore formation in tablets compressed from binary mixtures as a result of deformation and relaxation of particles.

B van Veen1, K van der Voort Maarschalk, G K Bolhuis, M R Visser, K Zuurman, H W Frijlink.   

Abstract

This paper describes the internal structure of tablets compressed from binary mixtures of sodium chloride and pregelatinised starch. The minimum particle diameter of pregelatinised starch inside tablets compressed from mixtures was calculated from the difference between the initial pore size distribution and the pore size distribution after removal of the starch particles by burning. Subsequently, the tablets were carefully crushed. These powders, consisting of almost only sodium chloride particles, were measured by laser diffraction. It was found that the diameter of the sodium chloride particles hardly changed, whereas the minimum diameter of starch particles strongly decreased during the compaction process. As an effect of the difference in yield pressure, the harder sodium chloride particles cause deformation of the softer starch particles, resulting in a change in particle shape. The pore size distribution of tablets compressed from mixtures of sodium chloride and starch is typically that of viscoelastic materials; the larger pores (>5 microm) change, while the small pores stay constant in number and size. The median pore diameter in tablets compressed from the mixtures is higher than the median pore diameter in tablets compressed from the pure materials. This paper shows that the formation of large pores was the result of the extra porosity expansion of tablets compressed from binary mixtures of sodium chloride and pregelatinised starch.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849914     DOI: 10.1016/s0928-0987(01)00216-0

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  Location-dependent analysis of porosity and pore direction in tablets.

Authors:  Yu San Wu; Henderik W Frijlink; Lucas J van Vliet; Ietse Stokroos; Kees van der Voort Maarschalk
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.